Amgen Stock Outlook: Is Wall Street Bullish or Bearish?

With a market cap of $151.2 billion, Amgen Inc. (AMGN) is a leading American biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen specializes in discovering, developing, manufacturing, and delivering human therapeutics and has grown into one of the world's largest independent biotech firms.

Shares of the drugmaker behemoth have underperformed the broader market over the past 52 weeks. AMGN has surged 1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 12.3%. However, AMGN stock has risen 7.9% on a YTD basis, outperforming SPX's 3.3% YTD dip.